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1130-224 Cardiac Magnetic Resonance Imaging: Comparison of 
Patients With Right Ventricular Outflow Tract 
Tachycardia and Arrhythmogenic Right Ventricular 
Dysplasia
Sei Iwai, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, Amit B. Guttigoli, Bindi 
K. Shah, Ravi K. Yarlagadda, Bruce B. Lerman, Cornell University Medical Center, New 
York, NY
Background: Cardiac magnetic resonance imaging (MRI) is a commonly used modality
to help differentiate patients with right ventricular outflow tract (RVOT) tachycardia and
those with arrhythmogenic right ventricular dysplasia (ARVD). Both of these groups of
patients present with monomorphic ventricular tachycardia (VT) arising from the right
ventricle. Methods and Results: Patients were diagnosed with ARVD and RVOT tachy-
cardia using standard clinical criteria. Thirteen ARVD patients underwent cardiac MRI; 5
had normal scans and 8 had findings suggestive of ARVD (including fatty infiltration,
fibrosis, and right ventricular wall thinning, hypokinesis, or dyskinesis). Thirty-seven
patients with RVOT tachycardia underwent cardiac MRI; of these 26 were normal and 11
were abnormal. Therefore, the positivity rate of MRI was 62% in ARVD pts, and the neg-
ativity rate in RVOT pts was 30%. Conclusions: These findings suggest that abnormali-
ties of the right ventricle seen on cardiac MRI appear to be nonspecific for ARVD. In
addition, the sensitivity of MRI imaging in detecting patients with ARVD is suboptimal, as
these pts not uncommonly have normal or only mildly abnormal cardiac MRI scans,
especially early in the disease process.
1130-225 New Simplified Technique for 3-D Mapping and Ablation 
of Right Ventricular Outflow Tachycardia
Moeen A. Saleem, Scott Burkett, Rod Passman, Samer Dibs, Erica Engelstein, Alan 
Kadish, Jeffrey Goldberger, Northwestern University, Chicago, IL
Background: Mapping and successful catheter ablation (ABL) of arrhythmias originating
from the right ventricular outflow tract (RVOT) requires 3-D localization in the vertical and
horizontal plane. The most efficient mapping technique remains to be determined.
Methods: Catheter ABL for RVOT ventricular tachycardia (n=12) or premature ventricular
beats (n=8) was performed in 20 cases (18 patients, age 40±15 years, 6 males). In group
1 (n=6), mapping was performed with a single ABL catheter and fluoroscopy. In group 2
(n=8), 3-D mapping using a non-contact mapping system (Endocardial Solutions, n=7) or
the Biosense electroanatomic system (n=1) was performed. In group 3 (n=6), 3-D map-
ping was performed with a circular multielectrode catheter (Lasso-n=5; Halo-n=1). The
Lasso catheter was advanced into the RVOT and its cranio-caudal position was opti-
mized to the earliest set of endocardial activation times identified on the Lasso during the
arrhythmia. At that level, endocardial activation times were simultaneously evaluated on
the circular catheter in the anterior, septal, posterior, or lateral plane. Based on this map,
the ABL catheter was directed toward the Lasso electrodes with the earliest endocardial
activation times. Further mapping in this area was done with the ABL catheter. All abla-
tions were with 4 mm tip catheters and used radiofrequency energy.
Results: The mean ±SD fluoroscopy time (minutes) was 71± 37, 55±18 and 39±13 for
groups 1, 2 and 3 p<0.1 by ANOVA, p<0.03 group 1 vs. 3 by Fisher’s. In group 2, there
were 2 tamponades, one prior to attempted ABL. In group 3, the Lasso became
entrapped in the tricuspid valve requiring surgery in 1 patient in whom catheter ABL was
not performed. Subsequent cases were done positioning the Lasso via a long SR0
sheath positioned across the valve. The acute success rate was 8/8 (100%), 5/7 (71%),
and 5/5 (100%) for groups 1, 2 and 3. The mean ±SD # of ABL lesions was 16.7 ±7.9,
13.7 ±8.3 and 16.0 ±28.6 for groups 1, 2 and 3 (p=0.9). The median # and range of
lesions was 19.5 (5-25), 12 (4-23), and 2 (1-67).
Conclusions: The use of a Lasso catheter for mapping the RVOT provides a simplified
technique to perform 3-D mapping for ablation of RVOT arrhythmias.
1130-226 Surface Electrocardiogram Clues to Localization of 
Ventricular Tachycardia to the Aortic Cusps
David Lin, Stuart J. Beldner, Ward Pulliam, Sultan Siddique, Erica S. Zado, Sanjay S. 
Dixit, David J. Callans, Francis E. Marchlinski, University of Pennsylvania Health System, 
Philadelphia, PA
Background
Repetitive monomorphic ventricular tachycardia (VT) occurring in the absence of struc-
tural heart disease typically originates in the outflow tract regions of the right and less
commonly the left ventricles. The ECG pattern for VT originating from right ventricular
outflow tract has been well described. However, a site of origin from the coronary cusps
has not been well documented and may be more common than previously recognized.
This study identifies surface electrocardiographic clues that suggest VT originating from
the aortic cusps.
Methods
A total of 8 patients undergoing ablation for VT had detailed (>150 points) 3D electro-
magnetic mapping (MEAM) and pacemapping performed from the aortic cusps and from
the endocardial aortomitral continuity (AMC) at threshold. The sites were identified and
tagged using MEAM, and confirmed by fluoroscopy and/or intracardiac echocardio-
graphy. The surface electrocardiograms (ECGs) were analyzed with pacing from each of
the left (LC) and right (RC) aortic valve cusps as well as the AMC. The QRS morphology
was recorded on the PruckaTM system at a sweep speed of 100 msec and analyzed off-
line.
Results
The mean QRS duration for LC pacing was 143msec (range 125-161msec), RC was
140msec (range 108-168msec), and AMC was 141msec (range 120-176msec). Lead V1
was found to be the most useful in distinguishing the different sites. LC pacing uniformly
produced a typical “m” or “w” shaped multiphasic pattern in V1, AMC pacing demon-
strated a qR pattern in V1, and RC pacing demonstrated a qS type of pattern in V1. The
R wave transition occurred earlier (ie by V2 in 8 of 8 patients) with LC and AMC pacing
than with RC pacing (by V3 or V4 in 6 of 8 patients and by V2 in only 2 patients).
Discussion
VT originating from the right and left aortic cusps and the adjacent endocardial aortomi-
tral continuity have distinct patterns on the 12-lead ECG that can be useful in identifying
the probable location of the VT and therefore the region to target for ablative therapy.
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1147-209 Spontaneous Implantable Defibrillator Shocks Do Not 
Increase Troponin T
Soufian Almahameed, Ahmad Abdhul-Karim, Ryan Zuzek, Janet Sparker, Jennifer E. 
Cummings, Nassir F. Marrouche, Andrea Natale, David O. Martin, The Cleveland Clinic 
Foundation, Cleveland, OH
Background: The presence of elevated cardiac enzymes after spontaneous implantable
defibrillator (ICD) discharges is frequently attributed to the shocks delivered. We tested
the hypothesis that the less specific cardiac enzymes CK and CK-MB would be related to
number of ICD shocks whereas the more specific cardiac enzyme troponin T (TnT) would
not.
Methods: Patients admitted to our institution because of one or more ICD shocks were
identified. Patients who had cardiac enzymes drawn within 24 hours of the last ICD shock
were included. Clinical data were abstracted from medical records. Number of ICD
shocks was obtained during interrogation of the ICD on admission. Correlation coeffi-
cients for the association between number of ICD shocks and cardiac enzyme level were
calculated for the cardiac enzymes CK, CK-MB, and TnT.
Results: A total of 73 patients with spontaneous ICD discharges and cardiac enzyme
measurements were included. The mean age of patients was 68.1 years, and 54 (74%)
were male. Mean peak CK was 371 +/- 31 U/L, mean peak CK-MB was 22.1 +/- 9 ng/ml,
and mean peak TnT was 0.47 +/- 0.8 ng/ml. Both peak CK (rho=0.34, p=0.005) and peak
CK-MB (rho=0.41, p=0.004) were significantly correlated with the number of spontane-
ous ICD discharges delivered. However, there was no correlation between TnT and the
number of spontaneous ICD discharges (rho=0.11, p=0.53). Of the 12 patients who had
TnT above the upper limit of normal, 11 (91%) had known coronary disease.
Conclusion: Although peak CK and peak CK-MB are correlated with the number of
spontaneous ICD discharges, peak TnT is not. An elevated TnT in a patient who has
received one or more spontaneous ICD discharges should not be attributed to delivered
ICD shocks, but does warrant evaluation for ischemia.
1147-210 Implantable Cardiac Defibrillator Interactions With 
Magnetic Resonance Imaging at 1.5 Tesla
James A. Coman, Jr., Edward T. Martin, David A. Sandler, J. Ryan Thomas, Oklahoma 
Heart Institute, Tulsa, OK, University of Oklahoma College of Medicine, Tulsa, OK
Background: Implantable cardiac defibrillators (ICDs) are considered an absolute con-
traindication to magnetic resonance imaging and angiography (MRI/MRA). Only limited
animal studies have been performed to assess the potential interactions between these
devices. From our experience, pacemaker patients have undergone MRI scanning with-
out difficulty. Given the design similarities, an assessment of the interaction between
ICDs and MRI scanners was thought to be warranted and reasonable.
Methods: Prospectively, 11 consecutive patients in need of cardiac, vascular and gen-
eral MRI testing, with varied ICD models and leads, were scanned. Battery impedance,
lead impedance, pacing threshold and sensing threshold were obtained prior to entering
the 1.5 Tesla magnet. Tachydysrhythmia detection and therapy were disabled, while
bradycardia therapy was left intact. Symptoms, non-invasive blood pressure and electro-
cardiographic signal were monitored continuously. Repeat ICD interrogation was per-
formed after the scan. Defibrillation threshold testing was performed on all systems after
the scan.
Results: There were no episodes of loss-of-capture or device movement during the
scan. Of the 14 leads scanned, none suffered a significant change in pacing threshold.
No changes were seen in lead impedance or sensing thresholds. All systems had
defibrillation thresholds that provided greater than the standard 10-Joule margin of
safety. One patient reported mild heating around the defibrillator at the time of spin echo
sequences. One patient experienced a brief, but asymptomatic, pause in pacing during
scanning. One patient underwent scanning with his device 1 month into the elective
replacement period. This device was found to be in a back-up mode after MRI scanning
and could not be interrogated. The device was sent for destructive testing, at which time
normal device function had returned. Circuit integrity was maintained.
Conclusions: In 10 of 11 patients with ICDs, MRI and MRA scanning in a 1.5 Tesla mag-
net was found to be safe under carefully controlled conditions. MRI scanning of ICDs with
low battery voltage may result in transient loss of function.
